Milestone Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,122
Closed -$488K 213
2025
Q1
$488K Buy
1,122
+24
+2% +$9.63K 0.1% 140
2024
Q4
$405K Buy
1,098
+297
+37% +$124K 0.09% 178
2024
Q3
$417K Buy
801
+19
+2% +$10.2K 0.09% 150
2024
Q2
$424K Buy
782
+64
+9% +$33.8K 0.11% 143
2024
Q1
$372K Buy
718
+215
+43% +$107K 0.11% 123
2023
Q4
$237K Buy
503
+30
+6% +$13.9K 0.08% 73
2023
Q3
$208K Buy
+473
New +$215K 0.07% 80

Other funds holding ELV

Milestone Asset Management's ELV Position: Q2 2025 in Review

Milestone Asset Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,122 shares — an estimated $488K sold.

Milestone Asset Management first reported a position in ELV in Q3 2023 and held it in 7 quarters. The position peaked at $488K in Q1 2025. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Milestone Asset Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Milestone Asset Management sold 1,122 Elevance Health shares in Q2 2025, an estimated $488K.
  • Milestone Asset Management first reported a position in Elevance Health in Q3 2023 and held it in 7 quarters.
  • Milestone Asset Management's Elevance Health position peaked at $488K in Q1 2025.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Milestone Asset Management's 13F filing for Q2 2025, filed 5 Aug 2025.